Dariohealth Quick Ratio (DRIO) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Dariohealth Corp   (NASDAQ: DRIO)

Dariohealth 's Quick Ratio

DRIO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 1.49 below Dariohealth Corp average.

Within Medical Equipment & Supplies industry 95 other companies have achieved higher Quick Ratio than Dariohealth in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 729 to 1652.

Explain Quick Ratio?
How much Cash & cash equivalents DRIO´s has?
What are DRIO´s Current Liabilities?




DRIO Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -1.8 % -51.15 % -43.96 % -50.76 % -43.99 %
Y / Y Cash & cash equivalent Change -35.71 % -27.75 % -21.14 % 95.79 % -6.83 %
Quick Ratio MRQ 1.49 2.17 2.36 3.46 2.27
DRIO's Total Ranking # 1652 # 729 # 761 # 663 # 850
Seq. Current Liabilities Change 2.36 % 0.36 % 0.47 % -4.87 % -49.08 %
Seq. Cash & cash equivalent Change -29.66 % -8.02 % -31.43 % 44.91 % -20.94 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 96
Healthcare Sector # 568
Overall Market # 1652


Quick Ratio Statistics
High Average Low
10.83 2.99 0.45
(Jun 30 2013)   (Dec 31 2016)




Financial Statements
Dariohealth 's Current Liabilities $ 10 Millions Visit DRIO's Balance sheet
Dariohealth 's Cash & cash equivalent $ 14 Millions Visit DRIO's Balance sheet
Source of DRIO's Sales Visit DRIO's Sales by Geography


Cumulative Dariohealth 's Quick Ratio

DRIO's Quick Ratio for the trailling 12 Months

DRIO Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -41.7 % -47.66 % -32.8 % -17.63 % 15.36 %
Y / Y Cash & cash equivalent TTM Growth -6.23 % 0.42 % 0.86 % -2.08 % -32.69 %
Quick Ratio TTM 2.36 2.56 2.2 2.01 1.47
Total Ranking TTM # 3814 # 2113 # 2433 # 2846 # 2863
Seq. Current Liabilities TTM Growth -0.47 % -20.62 % -13.34 % -14.86 % -10.63 %
Seq. Cash & cash equivalent TTM Growth -8.2 % -7.46 % -5.36 % 16.62 % -1.69 %


On the trailing twelve months basis In spite of the year on year decrease in DRIO's Current Liabilities to $9.58 millions, cumulative Quick Ratio to 2.36 below the DRIO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 198 other companies have achieved higher Quick Ratio than Dariohealth . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2113 to 3814.

Explain Quick Ratio?
How much Cash & cash equivalents DRIO´s has?
What are DRIO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 199
Healthcare Sector # 881
Within the Market # 3814


trailing twelve months Quick Ratio Statistics
High Average Low
5.66 2.62 0.98
(Jun 30 2021)   (Sep 30 2015)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions
Vivani Medical Inc   2.99 $ 19.894  Millions$ 6.659  Millions
Retractable Technologies Inc  2.98 $ 39.870  Millions$ 13.365  Millions
Neuropace Inc   2.97 $ 51.700  Millions$ 17.433  Millions
Apyx Medical Corp  2.95 $ 27.617  Millions$ 9.354  Millions
Omada Health Inc   2.94 $ 221.712  Millions$ 75.483  Millions
Clearpoint Neuro Inc   2.85 $ 29.363  Millions$ 10.313  Millions
Penumbra Inc  2.82 $ 658.795  Millions$ 233.776  Millions
Glaukos Corp  2.80 $ 286.594  Millions$ 102.329  Millions
Pulmonx Corporation  2.76 $ 56.393  Millions$ 20.405  Millions
Intuitive Surgical Inc   2.71 $ 5,216.200  Millions$ 1,922.900  Millions
Neuraxis Inc   2.69 $ 8.342  Millions$ 3.096  Millions
Edwards Lifesciences Corporation  2.68 $ 4,291.700  Millions$ 1,604.100  Millions
Modular Medical Inc  2.63 $ 3.920  Millions$ 1.489  Millions
Co diagnostics Inc   2.55 $ 7.299  Millions$ 2.863  Millions
Staar Surgical Co  2.47 $ 181.489  Millions$ 73.394  Millions
Electromed Inc   2.35 $ 20.450  Millions$ 8.714  Millions
EBR Systems, Inc.  2.18 $ 113.533  Millions$ 52.023  Millions
Medinotec Inc   2.15 $ 2.519  Millions$ 1.171  Millions

Date modified: 2026-09-26T07:11:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.